Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bionano Genomics, Inc. - Common Stock (NQ:BNGO)

1.930 +0.010 (+0.53%)
Streaming Delayed Price Updated: 2:39 PM EDT, Oct 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bionano Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
The 3 Best High-Risk, High-Reward Stocks to Buy Now: September 2023
The stock market's multiple challenges should dissipate soon, making now a good time to buy high-risk, high-reward stocks. 
Via InvestorPlace
7 F-Rated Meme Stocks to Avoid Like the Plague
Meme stocks are rarely a good idea. These popular meme stocks should be avoided at all costs – no matter what you may see on social media. 
Via InvestorPlace
These Are the ONLY 3 Meme Stocks to Consider in August 2023
While all meme stocks have been crushed, there are still a few meme stocks that look poised to eventually succeed. 
Via InvestorPlace
Why Bionano Genomics Stock Tanked Today
A CFO departure shines a light on some of the company's recent struggles. 
Via The Motley Fool
3 Top Short Squeeze Stocks for August 2023
With the bears pouncing on many strong growth names, many excellent short squeeze opportunities have been created. 
Via InvestorPlace
What's Going On With Bionano Genomics Stock?
Bionano Genomics, Inc. (NASDAQ: BNGO) shares are trading lower Monday. The company's stock began trading on a reverse split-adjusted basis on Monday. 
Via Benzinga
Bionano Genomics' Next-Gen Platform Set to Boost Throughput by 13x: Future of Cytogenetic Analysis Underway
 
Via Benzinga
Recap: Bionano Genomics Q1 Earnings
 
Via Benzinga
Earnings Outlook For Bionano Genomics
 
Via Benzinga
Bionano Genomics (BNGO) Q2 2023 Earnings Call Transcript
BNGO earnings call for the period ending June 30, 2023. 
Via The Motley Fool
Topics Earnings
DKNG Stock Alert: Wells Fargo Just Upgraded DraftKings
DraftKings (DKNG) stock is on the move Monday after getting an upgrade and new price target from Wells Fargo analyst Daniel Politzer. 
Via InvestorPlace
SOVO Stock Alert: Campbell Soup Is Buying Sovos Brands for $2.7 Billion
Sovos Brands (SOVO) stock is rising higher on Monday following news that Campbell Soup (CPB) is acquiring the Italian sauces company. 
Via InvestorPlace
BNGO Stock Alert: Bionano Just Reverse Split Its Stock
Bionano was a hot genetic analysis stock two years ago but now needed a reverse split so that BNGO stock could stay listed on the Nasdaq. 
Via InvestorPlace
Looking for a Bargain? 3 Biotech Stocks to Buy That Are Down 20%-60% in 2023
Since the pharmaceutical sector is very lucrative in America, these biotech stock bargains can be very profitable. 
Via InvestorPlace
7 Doomed Growth Stocks Destined for Disaster
Investing in growth stocks can be very expensive. Save yourself some time and money by avoiding these doomed growth stocks to sell. 
Via InvestorPlace
Why Shares of Bionano Genomics Are Up Monday
The life sciences company said it expects another improved quarter of revenue. 
Via The Motley Fool
The 7 Best Growth Stocks to Buy in July
With the macro environment favorable and many companies reporting strong results, here are the seven best growth stocks to buy. 
Via InvestorPlace
3 Penny Stocks with Multibagger Potential for the Second Half of 2023
If you have patience and a high risk tolerance, here are three penny stocks to watch in 2023 for their multibagger potential. 
Via InvestorPlace
7 Healthcare Stocks to Make You the Millionaire Next Door
For investors who want to greatly increase their wealth in the long term, these are the best healthcare stocks to buy. 
Via InvestorPlace
Over $1M Bet On Bioventus? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed lower by over 200 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2023
 
Via Benzinga
Hero or Zero? 3 High-Risk Penny Stocks to Make You Rich … or Broke.
Explore the world of high-risk penny stocks, with their potential for significant returns, as we analyze three speculative opportunities. 
Via InvestorPlace
Porch Group And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
The Dow Jones closed lower by over 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
3 Growth Stocks That Are Disrupting Their Industries in 2023
With many extremely powerful technologies proliferating, it's easer than ever to find disruptive growth stock winners. 
Via InvestorPlace
Bionano Genomics (BNGO) Q1 2023 Earnings Call Transcript
BNGO earnings call for the period ending March 31, 2023. 
Via The Motley Fool
Better Gene Sequencing Stock: Illumina vs. Bionano Genomics
This is a classic matchup of a grizzled top dog against a scrappy competitor. 
Via The Motley Fool
7 Growth Stocks With Huge Return Potential for Long-Term Investors
Overdone worries about a recession are poised to disappear, causing many excellent growth stocks to soar in the coming months. 
Via InvestorPlace
7 Stocks That Could Skyrocket in the Next 12 Months
With the macro environment becoming excellent and much of the Street starting to turn bullish, it's time to find superb stocks to buy. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.